Healthtech Startups

Tangelo is a healthcare platform that prescribes personalized food interventions to help people manage chronic conditions and prevent disease. It serves payers and healthcare providers seeking to improve health outcomes and reduce costs at the population level.

1 investor

Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options. The company serves contact lens wearers, optometrists, ophthalmologists, and lens manufacturers.

1 investor

Taninpardaz Pasargad develops cochlear implant systems and hearing-related medical devices and services for deaf and hard-of-hearing patients in Iran.

1 investor

Tap Medical is an online platform that lets patients find and book medical appointments, including walk-in visits, family doctor consultations, virtual doctor or nurse practitioner visits, and specialist care such as radiology and cardiology. It also offers clinics tools to manage appointment bookings, serving patients and healthcare providers in the Montreal, Quebec area.

1 investor

TareBio operates a platform for developing personalized and population-level vaccines against cancer and infectious diseases by analyzing immune cells already responding to a disease and reverse-engineering the antigens that activate them. The company works in the biotechnology and vaccine development space.

1 investor

1 investor

Target100 is a weight loss and wellness program based on a best-selling book that combines behavioral science, human support, and simple technology into a customizable plan. It offers a holistic mind-body approach with guidance from real people for individuals seeking lasting weight loss.

1 investor

Tarjimly operates a language interpretation and translation service connecting professional and volunteer bilinguals to refugees, immigrants, and humanitarian organizations. The platform uses AI/ML matching to provide HIPAA and GDPR-compliant remote interpretation services across 250+ language pairs, with paid services funding free access for refugees and displaced populations.

1 investor

Tarkka makes Tetrx, a custom wheelchair seating system designed to prevent pressure injuries and improve comfort for wheelchair users. The product tailors seating to individual body shapes as a medical device in the mobility and assistive-device space.

1 investor

Tarsons manufactures a range of plastic labware products for life sciences research, including bottles, flasks, centrifuge ware, cryo labware, and liquid handling systems. The company serves academic, pharmaceutical, biotechnology, clinical research, and industrial customers across 40+ countries.

1 investor

Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.

1 investor

Tasmanian Aboriginal Centre is an Aboriginal community organisation that provides health, aged care, cultural, educational, and community support services to the Tasmanian Aboriginal community. Established in the early 1970s and incorporated in 1973, it represents the political and community development aspirations of Tasmania's Aboriginal population.

1 investor

Tata Capital Healthcare Fund is a private equity fund focused on investing in healthcare and life sciences businesses in India. It manages multiple fund vintages (TCHF I, II, and III) that back companies across the healthcare sector.

1 investor

TATUM bioscience develops biotech solutions, though the page provides limited detail on specific products or target markets.

1 investor

TAU Medical develops Pivot-TR, a minimally invasive transcatheter valve support system for treating tricuspid regurgitation, delivered via a transfemoral approach without open-heart surgery. The platform offers permanent (Pivot Extend) and temporary (Pivot Bridge) implants that use non-fixated, atraumatic anchoring to restore valve coaptation for physicians treating high-risk cardiac patients.

1 investor

TauC3 Biologics is a biotechnology company developing therapies for neurodegenerative diseases, with a focus on tau-related and Alzheimer's disease drug discovery. It brings together drug development and neuroscience expertise to advance treatments for CNS disorders.

1 investor

Taudia develops ultrasensitive biomarker detection technology for neurodegenerative disease quantitation, serving researchers, biopharma teams, and clinicians through blood-based diagnostic tools.

1 investor

Tavo Biotherapeutics develops novel treatments for glaucoma and retinal diseases, focusing on disease-modifying therapies that target the root biological mechanisms of vision loss. The company is advancing TAV-001, a topical therapy that modulates the autonomic nervous system to reduce intraocular pressure, improve blood flow to the optic nerve, and provide neuroprotection.

1 investor

Taxa collaborates with government administrations and businesses to deliver technology solutions that improve community engagement and administrative operations.

1 investor

Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions. Its lead clinical program targets Rett syndrome, alongside a broader pipeline of CNS programs.

1 investor

TAZ develops anti-aging products and drug discovery research focused on cellular senescence removal and longevity science. The company provides biomarker testing services, contract product development, and drug candidates to extend healthspan in an aging society.

1 investor

Tazki provides AI-assisted accident investigation software for occupational safety teams, helping to document witness accounts, identify root causes, and propose corrective measures. The platform is used by Chilean companies and holds official recognition from Chile's Department of Labor.

1 investor

TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.

1 investor

Team CarePal offers a free mobile app and connected care ecosystem for family care partners in Canada, providing burnout assessments, resource matching, and an AI support assistant (Zolo). It also sells programs to hospitals, senior care homes, and community organizations to support caregivers across hospital-to-home, community, and senior care settings.

1 investor